References
- Colao A, Amato G, Pedroncelli A-M, Baldelli R, Grottoli S, Gasco V et al. Gender and age-related differences in the endocrine parameters of acromegaly. J Endocrinol Invest. 2002 Jun;25(6):532-8. PubMed | Google Scholar
- Kauppinen-Mäkelin R, Sane T et al. A nationwide survey of mortality in acromegaly. J Clin Endocrinol Metab. 2005 Jul;90(7):4081-6. Epub 2005 May 10. PubMed | Google Scholar
- Minniti G, Esposito V, Piccirilli M et al. Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature. Eur J Endocrinol. 2005 Dec;153(6):723-35. PubMed | Google Scholar
- Tanimoto K, Hizuka N, Fukuda I, Takano K, Hanafusa T. The influence of age on the GH-IGF1 axis in patients with acromegaly. Eur J Endocrinol. 2008 Oct;159(4):375-9. PubMed | Google Scholar
- Petersenn S, Buchfelder M, Gerbert B, Franz H, Quabbe HJ, Schulte HM et al. Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register. Clin Endocrinol (Oxf). 2009 Sep;71(3):400-5. PubMed | Google Scholar
- Agha A, Monson JP. Modulation of glucocorticoid metabolism by the growth hormone – IGF-1 axis. Clinical Endocrinology. 2007 Apr;66(4):459-65. PubMed | Google Scholar
- Sheehan HJM, Douds GL, Hill K, Farace E. Transsphenoidal surgery for pituitary adenoma in elderly patients. Act Neurochir. 2008 Jun;150(6):571-4; discussion 574. PubMed | Google Scholar
- Arita K, Hirano H, Ynoue S et al. Treatment of elderly acromegalics. Endocr J. 2008 Oct;55(5):895-903. Epub 2008 Jun 14. PubMed | Google Scholar
- Bevan JS, Atkin SL, Atkinson AB et al. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow release octreotide on growth hormone, insuline-like growth factor-I, and tumor size. J Clin Endocrinol Metab. 2002 Oct;87(10):4554-63. PubMed | Google Scholar
- Colao A, Auriemma RS, Rebora A et al. Significant tumour shrinkage after 12 months of Lanreotide Autogel-120 mg treatment given first-line in acromegaly. Clin Endocrinol. 2009 Aug;71(2):237-45. PubMed | Google Scholar
- Minniti G, Jaffrain-ReaML,Osti M et al. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas?. Clin Endocrinol. 2005 Feb;62(2):210-6. PubMed | Google Scholar
- Jallad RS, Musolino NR, Salgado LR, Bronstein MD. Treatment of acromegaly: is there still a place for radiotherapy ?. Pituitary. 2007;10(1):53-9. PubMed | Google Scholar
- Nachtigall L, Delgado A, Swearingen B et al. Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab. 2008 Jun;93(6):2035-41. PubMed | Google Scholar